Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,064 Hematology
clinical trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Marjorie Weinberg Cancer Center at Loyola-Gottlieb
mi
from
Melrose Park, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Medical Center-Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
21st Century Oncology-Pontiac
mi
from
Pontiac, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Hope Cancer Center
mi
from
Pontiac, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Huron Gastroenterology PC
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan-Kettering Cancer Center - New York
mi
from
New York, NY
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Anchorage Associates in Radiation Medicine
mi
from
Anchorage, AK
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fredericksburg, VA
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Midland, MI
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ogden, UT
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Orange City, FL
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tinley Park, IL
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Zanesville, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Texas Oncology - San Antonio Northwest
mi
from
San Antonio, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Thalassemia Clinical Trial
A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia
Status: Enrolling, Phase II
Updated: 12/31/1969
University Health Network - Toronto General Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
Spruce Biosciences Clinical Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
University Hospital Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Fabry Disease Clinical Trial
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Minnesota - Pediatric Gene Therapy
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Aurora, CO
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
Status: Enrolling, Phase
Updated: 12/31/1969
Medical College of Wisconsin; Department of Obstetrics and Gynecology
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling, Phase
Updated: 12/31/1969
Advanced Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling, Phase
Updated: 12/31/1969
West Coast Medical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Benign Prostatic Hyperplasia Clinical Trial
Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH)
Status: Enrolling, Phase
Updated: 12/31/1969
University of Kansas Health System
mi
from
Kansas City, KS
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
Kansas City Regional Hemophilia Center
mi
from
Kansas City, KS
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
Arizona Hemophilia and Thrombosis Center at Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Siteman Cancer Center at West County Hospital
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Mercy Health Perrysburg Cancer Center
mi
from
Perrysburg, OH
Click here to add this to my saved trials
Chronic Graft-versus-host Disease Clinical Trial
GRAVITAS-309: Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
St. David's South Austin Medical Center
mi
from
Austin, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)
Status: Enrolling, Phase II
Updated: 12/31/1969
GSK Investigational Site
mi
from
Calgary,
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Seoul National University Hospital
mi
from
Seoul,
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Status: Upcoming, Phase II
Updated: 12/31/1969
University of Iowa Stead Family Children's Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
Hematology Clinical Trial
Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
Status: Upcoming, Phase II
Updated: 12/31/1969
Stanford Cancer Institute Palo Alto
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV)
Status: Upcoming, Phase II
Updated: 12/31/1969
UZ Gent
mi
from
Gent,
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders
Status: Upcoming, Phase I
Updated: 12/31/1969
The University of Michigan Rogel Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Other, Reproductive Clinical Trial
PHIL® Embolic System Pediatric IDE
Status: Upcoming
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV)
Status: Upcoming, Phase II
Updated: 12/31/1969
American Institute of Research (AIR)
mi
from
Whittier, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Research Site
mi
from
Adelaide,
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Encinitas, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Watertown, SD
Click here to add this to my saved trials
Hematology Clinical Trial
Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
Status: Upcoming, Phase II
Updated: 12/31/1969
Levine Cancer Institute/Carolinas Health Care System
mi
from
Charlotte, NC
Click here to add this to my saved trials
Hematology Clinical Trial
VerifyNow® Aspirin Test and PRUTest Platelet Reactivity Compared to the AggRAM Aggregometer
Status: Upcoming, Phase
Updated: 12/31/1969
Accriva Study Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Relapsed Refractory Multiple Myeloma Clinical Trial
Myeloma-Developing Regimens Using Genomics (MyDRUG)
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Amyloid Cardiomyopathy, Transthyretin-Related Clinical Trial
Screening for Cardiac Amyloidosis Using Nuclear Imaging for Minority Populations
Status: Upcoming, Phase
Updated: 12/31/1969
Harlem Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology Clinical Trial
Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases
Status: Upcoming, Phase II, III
Updated: 12/31/1969
Stanford Cancer Center - Palo Alto
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV)
Status: Upcoming, Phase II
Updated: 12/31/1969
The Oncology Institute of Hope and Innovation
mi
from
Tucson, AZ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma
Status: Upcoming, Phase
Updated: 12/31/1969
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Clinical Trial
Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects
Status: Upcoming, Phase I, II
Updated: 12/31/1969
University Hospitals Cleveland Medical Center, Rainbow Babies & Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow Transplant
Status: Upcoming
Updated: 12/31/1969
Penn State Cancer Institute
mi
from
Hershey, PA
Click here to add this to my saved trials
1 … 113 114 115 116 117 118 119 120 121